Frances K Bennett

Title: Frances K Bennett: Innovator in Immunology

Introduction

Frances K Bennett is a notable inventor based in Sudbury, MA (US). She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of 3 patents, her work focuses on modulating immune responses, which has important implications for treating various diseases.

Latest Patents

One of her latest patents is titled "Nucleic acids encoding antibodies against PD-1." This disclosure provides antibodies and antigen-binding fragments that can act as agonists and/or antagonists of PD-1 (Programmed Death 1). These innovations are designed to modulate immune responses, particularly those mediated by TcR and CD28. The disclosed compositions and methods may be utilized in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, and other immune system disorders. Another significant patent is "Methods of upmodulating adaptive immune response using anti-PD-1 antibodies," which shares similar applications and benefits in the field of immunotherapy.

Career Highlights

Frances K Bennett has worked with prominent companies in the biotechnology sector, including Wyeth and Medimmune Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Some of her notable coworkers include Mary Collins and Clive R Wood. Their collaborative efforts have likely played a role in the development of her patents and innovations.

Conclusion

Frances K Bennett's contributions to immunology through her patents demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact the treatment of various immune-related disorders.